Taipei Exchange - Delayed Quote TWD

Visgeneer Inc. (4197.TWO)

Compare
9.78
0.00
(0.00%)
As of 10:46:59 AM GMT+8. Market Open.
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
147,994.00
147,994.00
157,964.00
165,286.00
175,962.00
Cost of Revenue
80,512.00
80,512.00
90,638.00
98,020.00
113,714.00
Gross Profit
67,482.00
67,482.00
67,326.00
67,266.00
62,248.00
Operating Expense
68,448.00
68,448.00
63,654.00
64,030.00
63,187.00
Operating Income
-966.00
-966.00
3,672.00
3,236.00
-939.00
Net Non Operating Interest Income Expense
-1,727.00
-1,727.00
-2,407.00
-2,135.00
-2,518.00
Pretax Income
-19,589.00
-19,589.00
12,345.00
1,328.00
-2,427.00
Tax Provision
--
--
--
508.00
-3,030.00
Net Income Common Stockholders
-19,589.00
-19,589.00
12,345.00
820.00
603.00
Diluted NI Available to Com Stockholders
-19,589.00
-19,589.00
12,345.00
820.00
603.00
Basic EPS
-0.65
--
0.41
0.03
0.02
Diluted EPS
-0.65
--
0.41
0.03
0.02
Basic Average Shares
30,181.00
--
30,181.00
30,181.00
30,181.00
Diluted Average Shares
30,181.00
--
30,181.00
30,181.00
30,181.00
Total Expenses
148,960.00
148,960.00
154,292.00
162,050.00
176,901.00
Net Income from Continuing & Discontinued Operation
-19,589.00
-19,589.00
12,345.00
820.00
603.00
Normalized Income
604.00
604.00
12,345.80
800.86
435.80
Interest Income
1,656.00
1,656.00
494.00
168.00
374.00
Interest Expense
3,383.00
3,383.00
2,901.00
2,303.00
2,892.00
Net Interest Income
-1,727.00
-1,727.00
-2,407.00
-2,135.00
-2,518.00
EBIT
-16,206.00
-16,206.00
15,246.00
3,631.00
465.00
EBITDA
973.00
973.00
34,436.00
19,189.00
20,887.00
Reconciled Cost of Revenue
80,512.00
80,512.00
90,638.00
98,020.00
113,714.00
Reconciled Depreciation
17,179.00
17,179.00
19,190.00
15,558.00
20,422.00
Net Income from Continuing Operation Net Minority Interest
-19,589.00
-19,589.00
12,345.00
820.00
603.00
Total Unusual Items Excluding Goodwill
-20,193.00
-20,193.00
-1.00
31.00
209.00
Total Unusual Items
-20,193.00
-20,193.00
-1.00
31.00
209.00
Normalized EBITDA
21,166.00
21,166.00
34,437.00
19,158.00
20,678.00
Tax Rate for Calcs
--
--
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
-0.20
11.86
41.80
12/31/2020 - 10/24/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6744.TWO Feng Chi Biotech Corp.
19.70
0.00%
 
4170.TWO VBI
13.80
-1.43%
 
6709.TWO Advagene Biopharma Co., Ltd.
20.20
0.00%
 
6652.TWO Eusol Biotech Co.,Ltd.
7.49
-4.07%
 
6814.TWO Lukas Biomedical Inc.
27.60
0.00%
 
6827.TWO MegaPro Biomedical Co., Ltd
14.45
+2.48%
 
4194.TWO Holy Stone Healthcare Co., Ltd.
11.30
-1.31%
 
6610.TWO TWi Biotechnology, Inc.
13.75
+0.73%
 
4732.TWO NatureWise Biotech & Medicals Corporation
23.05
+0.22%
 
6999.TWO Han Biomedical
36.00
+3.75%